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Renal Dysplasia 
Halana Whitehead, M.D. 
 
Overview 
Renal dysplasia (RD) is characterized by abnormal differentiation of the nephrons and collecting 
ducts, decreased nephron number, increased stromal elements and the presence of metaplastic 
tissues such as cartilage.1–3  RD is part of a group of disorders known as Congenital Anomalies 
of the Kidney and Urinary Tract (CAKUT).  These disorders represent approximately 70% of 
pediatric chronic kidney disease.3  Dyplastic kidneys vary in size and in the presence of cysts.  
The spectrum of RD ranges from small- or normal-sized kidneys, with or without cysts, to 
markedly enlarged kidneys with significant cystic changes.2  An extreme phenotype of RD are 
multicystic dysplastic kidneys (MCDK). Renal hypodysplasia refers to small dysplastic kidneys 
without gross cystic changes.3 
 
Epidemiology 
Unilateral RD occurs in 1 in every 3,000 to 5,000 births and bilateral dysplasia occurs in 1 in 
every 10,000 births.1,3 The incidence of CAKUT in general is 0.3 to 1.6 per 1,000 births.3  
Bilateral RD, in particular hypodysplasia, is the most common cause of chronic renal failure in 




The pathogenesis of RD is multifactorial with numerous causes thus far identified including 
genetic mutations and drug exposures, but in most cases a cause is never identified.  In 
humans, kidney development begins at 4 weeks gestation in a sequential pattern.  Two 
transient structures, the pronephros and mesonephros, develop prior to the formation of the 
metanephros.  The metanephros is a permanent embryologic structure which develops into the 
mature kidney.  The initial step of metanephric development is the formation of the ureteric bud.  
This is an out-growth of epithelial cells from the distal aspect of the Wolffian duct.  The ureteric 
bud continues to grow from the reciprocal interactions of the ureteric epithelium and the 
surrounding metanephric mesenchyme. This reciprocal interaction induces branching 
morphogenesis in a stereotypic pattern of kidney formation.  When the ureteric bud develops in 
an abnormal location this alters the interaction between the ureteric bud and the metanephric 
mesenchyme leading to abnormal renal differentiation and RD.5,6  RD also develops when lower 
urinary tract obstruction occurs during fetal development.  Lower urinary tract obstruction in 
animal models has caused renal dysplasia, but the cystic changes seen in these models are 
less prominent.  Metaplastic tissues are absent, demonstrating that there are likely additional 
factors at play in human disease.1  Studies have also demonstrated an imbalance of cell 
proliferation and programmed cell death in human RD.  Proliferative factors such as PAX2 and 
BCL2 are overexpressed in cystic epithelia in RD.  Dysplastic kidneys have also been shown to 
have more apoptotic cells than their normal counterparts which may explain the tendency for 
involution in RD.6 
 
Genetics 
The majority of human RD occurs sporadically, but some studies have found clustering of renal 
abnormalities in families of patients with severe RD.2  The most common renal abnormality seen 
with a familial pattern is unilateral agenesis, which, given RD’s tendency to involute, may 
represent a history of unilateral RD.2 
Numerous syndromes are associated with RD and CAKUT, including Beckwith-Wiedemann, 
DiGeorge, Meckel-Gruber and Fanconi anemia.  Of particular interest is an entity known as 
Renal Cysts and Diabetes (RCAD) syndrome which is caused by mutations in the transcription 
factor HNF1b.  RCAD features glucose intolerance or diabetes and renal malformations 
including RD, polycystic kidneys and solitary kidney.  Uterine malformations have been reported 
in women with RCAD.   RCAD can occur secondary to a de novo mutation or inherited in a 
dominant pattern.1,6  RCAD may go undiagnosed in families until a child with a more severe 
renal phenotype is born.  Additionally, mutations in the gene encoding HNF1b have been seen 
in patients with prenatally diagnosed renal abnormalities even in the absence of a family history 
concerning for RCAD.1 
Additional genes implicated in RD included PAX2 and uroplakins.  PAX2 has been shown in 
mouse models to cause renal agenesis in null mutants and renal hypoplasia in heterozygotes.  
PAX2 overexpression has been shown to cause RD and cystic changes.  PAX2 mutations in 
humans cause renal-coloboma syndrome andhave also been associated with hypertension.1  
Uroplakins are a group of proteins expressed on the urothelial surface.  Uroplakin II and IIIA 
mutations have been demonstrated in patients with severe RD and uroplakin mutations have 
also been linked to VUR.1 
 
Diagnosis and Clinical Presentation 
RD is technically a histologic diagnosis, but can be deduced from imaging, particularly 
ultrasonography.2   RD is often first identified on prenatal ultrasonography.  CAKUT represent 
one third of abnormalities detected on routine prenatal ultrasound.6  A study by Fraser et al. of 
53 RD patients in the U.K. reported that 60% were diagnosed by prenatal ultrasonography, with 
the majority detected during the 20 week anatomic survey.7   
Features of prenatally diagnosed RD include renal size discrepancy, renal pelvic dilation, and 
cystic changes.1,2,7  Dysplastic kidneys can be small or enlarged, although there is likely an 
early diagnostic bias for enlarged kidneys, which are easier to visualize.1,2  When one kidney is 
noted to be abnormal, a careful examination of the contralateral kidney is required as 30-50% 
will have additional abnormalities.2  Decreased amniotic fluid volume is associated with severe 
bilateral disease and often leads to an earlier diagnosis of RD.1,2   RD may also be associated 
with lower urinary tract abnormalities.  Bilateral MCDK in particular is often associated with 
ureteric atresia.2  It is important to note that the renal phenotype can evolve over the course of 
the pregnancy.  Resolution occurs in some cases, but abnormalities may also become more 
prominent.1,2 
When there is concern for RD on prenatal ultrasound, a detailed anatomic assessment of the 
fetus should be performed as one third have abnormalities in other organ systems.2  
Assessment for additional anomalies is also important to evaluate the potential for a multi-organ 
system genetic syndrome as the cause.  Additional abnormalities may determine if 
chromosomal analysis is indicated.1,2  Further work-up for prenatally diagnosed RD should 
include a detailed family history for both renal disease and conditions such as diabetes to 
assess for inherited causes and risk of disease in future children.  Renal ultrasound screening of 
first-degree relatives should also be considered.2  Assessment for inherited causes is important 
both for the fetus’s prognosis and for assessing recurrence risk with future pregnancies, which 
is low in the absence of inherited causes (approximately 2-3%).2   
When RD is not diagnosed prior to birth, diagnosis often occurs in the neonatal period when an  
ultrasound is ordered due concerning physical exam findings (abdominal mass, palpable 
bladder, etc.), laboratory abnormalities (mainly elevated creatinine) or the presence of 
conditions associated with renal abnormalities which prompt screening.7  The Fraser et al. study 
noted that of the 40% of patients diagnosed postnatally, half came to attention in the neonatal 
period.  Many of the remaining patients presented within the first two years of life with UTI.7 
 
Management and Outcomes 
The course and prognosis of RD depends primarily on 2 factors: 1) whether the patient’s RD 
associated with a genetic syndrome and 2) whether the RD is unilateral or bilateral.  In the case 
of RD associated with a syndrome, the prognosis is largely dependent on the presence of extra-
renal abnormalities such as cardiac and neurologic disease.1   
In the case of isolated/(non-syndromic) RD, bilateral RD carries a worse prognosis, particularly 
if it associated with oligohydramnios and poor renal growth or involution in utero.  This can lead 
to pulmonary hypoplasia (Potter’s sequence) and many infants die in the neonatal period from 
respiratory failure.  In cases of less severe pulmonary disease, but with poor kidney function 
dialysis can be considered but is technically difficult in neonates.1,2  In patients with less severe 
bilateral RD, the onset of renal failure is usually later, making renal replacement therapy easier 
to manage and, once a child is 10 kg or greater, renal transplant becomes a therapeutic 
option.1,2   
Unilateral RD has a significantly better prognosis, particularly if the contralateral kidney is 
normal.  Most dysplastic kidneys ultimately involute without issue.  This results in compensatory 
hypertrophy of the contralateral kidney. 2  Compensatory hypertrophy may even begin 
prenatally.  In the majority of patients with isolated unilateral disease, renal failure and 
decreased renal function do not develop, but nearly half have hypertension in adulthood.2  
Historically it was believed that the dysplastic kidney conferred an increased risk of renal 
tumors, but this has not borne out in more recent studies.  As such, elective nephrectomy is no 
longer recommended unless there is another indication.1,2 
While prognosis is difficult to determine prenatally, post-natal glomerular filtration rate (GFR) 
has been shown to have some predictive value.  A GFR <15 mL/min per 1.73m2 at 6 months or 
<25 mL/min per 1.73m2 at 18 months has been associated with a worse prognosis, although 
more recent studies indicate that GFR at age 5 may be more predictive of long-term renal 
function due to delayed renal growth.1,2  Additionally, poor postnatal renal growth in both 
unilateral and bilateral RD, renal scarring and the presence of posterior urethral valves or VUR 
are associated with poorer outcomes.7  In cases of RD associated with lower urinary tract 
obstruction, prognosis cannot be determined until after the obstruction is corrected.2 
In both unilateral and bilateral RD, referral to a pediatric nephrologist should be made promptly 
after the diagnosis of RD so that progression and renal growth can be closely monitored.  In the 
case of certain lower urinary tract abnormalities such as vesicoureteral reflux (VUR), antibiotic 
prophylaxis may be indicated to prevent UTI and subsequent renal scarring.1  The role of other 
medications in RD remains unclear.  ACE inhibitors and ARBs may help improve long-term 
renal function in RD, as they do in adults with proteinuric CKD, but this has not been well-
studied to date.2 
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